Home-based pulmonary rehabilitation has been slowly gaining momentum for chronic obstructive pulmonary disease (COPD), but ...

For COPD patients, the adage holds true: "the first way to get out of a hole is to quit digging one," said Christopher Mosher ...

Sanofi and Regeneron have reported that the Phase III AERIFY-1 trial of the fully human monoclonal antibody itepekimab.

A Winnipeg woman who was given a life expectancy of six months after cancer metastasized from her lungs to her brain, liver ...

Canadian wildfire smoke has entered the Upper Midwest and poses significant health impacts in the hardest-hit areas.

Last fall, the hospital’s pharmacy team launched an effort aimed at cutting readmission rates for COPD, which are notoriously ...

Researchers warn of increased cannabis use among older US adults, as experts link it to health risks and complications in ...

Topline results were announced from two phase 3 trials evaluating itepekimab in former smokers with inadequately controlled COPD.

People who lost weight in midlife were less likely to experience heart attacks, strokes, cancer, asthma or chronic ...

In light of the significant drop in Regeneron’s stock price, a natural question emerges: is REGN now a viable buying ...